Enlaza Therapeutics
San Diego, US · 6 known investors
Enlaza Therapeutics develops covalent protein therapeutics using its War-Lock technology, which incorporates proprietary unnatural amino acids into protein drugs so they form irreversible covalent bonds with disease-related targets. The company applies this synthetic biology platform to engineer biologics with improved efficacy and safety for treating cancer and other serious diseases.
BiotechDeep Tech
Founders & leadership
SD
SM
Sanford MadiganinCo-Founder, President & Chief Business OfficerManaging Partner at Avalon BioVentures
AH
Analeah HeidtChief Scientific Officer
Investors · 6
Frequently asked questions
- What does Enlaza Therapeutics do?
- Enlaza Therapeutics develops covalent protein therapeutics using its War-Lock technology, which incorporates proprietary unnatural amino acids into protein drugs so they form irreversible covalent bonds with disease-related targets. The company applies this synthetic biology platform to engineer biologics with improved efficacy and safety for treating cancer and other serious diseases.
- Who founded Enlaza Therapeutics?
- Enlaza Therapeutics was founded by Sergio Duron, Sanford Madigan.
- Who are Enlaza Therapeutics's investors?
- Enlaza Therapeutics's investors include Frazier Life Sciences, Lightspeed Venture Partners, Samsara BioCapital, Avalon BioVentures, Pfizer Venture Investments, OrbiMed.
- Where is Enlaza Therapeutics headquartered?
- Enlaza Therapeutics is headquartered in San Diego, US.